30 related articles for article (PubMed ID: 14991535)
1. A study on immunohistochemical expression of HER2/Neu and p63 and its association with grade and invasiveness in case of bladder carcinoma.
Sinha S; Choudhury S; Mishra J; Kundu G; Bera MK; Mondol PP
Urologia; 2024 May; 91(2):284-288. PubMed ID: 38390685
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette-Guerin.
Hegazy R; Kamel M; Salem EA; Salem NA; Fawzy A; Sakr A; El-Farargy O; Nawar N; El-Atar A; Shahin AM; Hegazy A
Arab J Urol; 2015 Sep; 13(3):225-30. PubMed ID: 26413353
[TBL] [Abstract][Full Text] [Related]
3. The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period.
Yohana C; Bakuza JS; Kinung'hi SM; Nyundo BA; Rambau PF
Infect Agent Cancer; 2023 Feb; 18(1):10. PubMed ID: 36800971
[TBL] [Abstract][Full Text] [Related]
4. Programmed Cell Death-Ligand-1 expression in Bladder Schistosomal Squamous Cell Carcinoma -
Madureira AC
Front Immunol; 2022; 13():955000. PubMed ID: 36148227
[No Abstract] [Full Text] [Related]
5. Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.
Al-Ezzi EM; Veitch ZW; Salah SH; Van der Kwast TH; Stockley TL; Selvarajah S; Zhang T; Sridhar SS; Sacher AG; Fallah-Rad N; Kulkarni GS; Zlotta AR; Finelli A; Hansen AR
PLoS One; 2021; 16(12):e0259272. PubMed ID: 34851968
[TBL] [Abstract][Full Text] [Related]
6. P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.
Santos J; Fernandes E; Ferreira JA; Lima L; Tavares A; Peixoto A; Parreira B; Correia da Costa JM; Brindley PJ; Lopes C; Santos LL
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3329. PubMed ID: 25502795
[TBL] [Abstract][Full Text] [Related]
7. Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients.
Rambau PF; Chalya PL; Jackson K
Infect Agent Cancer; 2013 May; 8(1):19. PubMed ID: 23705833
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder.
El Gehani K; Al-Kikhia L; Emaetig F; Syrjänen K; Al-Fituri O; Elzagheid A
Libyan J Med; 2012; 7():. PubMed ID: 22408683
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
Wolf HK; Stöber C; Hohenfellner R; Leissner J
Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
[TBL] [Abstract][Full Text] [Related]
10. ["Marker" of radioresistance in squamous cell carcinoma of the head and neck: a clinicopathologic and immunohistochemical study].
Budach W
Strahlenther Onkol; 1998 May; 174(5):286-8. PubMed ID: 9614960
[No Abstract] [Full Text] [Related]
11. [The role of tumor markers in prognosing transitional bladder cancer].
Lorenzo Gómez MF; Schroeder G
Actas Urol Esp; 2003; 27(7):501-12. PubMed ID: 12938579
[TBL] [Abstract][Full Text] [Related]
12. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1).
Badr KM; Nolen JD; Derose PB; Cohen C
Hum Pathol; 2004 Feb; 35(2):184-9. PubMed ID: 14991535
[TBL] [Abstract][Full Text] [Related]
13. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.
Abdulamir AS; Hafidh RR; Kadhim HS; Abubakar F
J Exp Clin Cancer Res; 2009 Feb; 28(1):27. PubMed ID: 19243595
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
